Orthotopic Model of Human Glioblastoma
https://doi.org/10.33647/2713-0428-20-3E-35-37
Abstract
The tumorigenic potential of A172, U251, and U87 glioblastoma cells has been studied in mice of the NODscid line.
About the Author
N. A. Goryacheva
Pushchino Branch of the Russian Biotechnological University;
Branch of the Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences
Russian Federation
Russian Federation
Natalya A. Goryacheva
142290, Moscow Region, Pushchino, Nauki Ave., 3;
142290, Moscow Region, Pushchino, Nauki Ave., 6
References
1. Gens G.P., Sanikovich V.D., Milejko V.A., Lebedeva A.A. Glioblastoma: molekulyarno-geneticheskiy portret i sovremennye terapevticheskie strategii lekarstvennogo lecheniya [Glioblastoma: A molecular genetic portrait and modern therapeutic strategies for drug treatment]. Uspekhi molekulyarnoy onkologii [Advances in Molecular Oncology]. 2021;8(3):60–76. (In Russian). DOI: 10.17650/2313-805X-2021-8-3-60-76
2. Zavjalov E.L., Razumov I.A., Gerlinskaya L.A., Romashchenko A.V. In vivo MRTvizualizatsiya dinamiki razvitiya glioblastomy U87 v modeli ortotopicheskoy ksenotransplantatsii mysham linii SCID [In vivo MRI visualization of growth and morphology in the orthotopic xenotrasplantation U87 glioblastoma mouse SCID model]. Vavilovskiy zhurnal genetiki i selektsii [Vavilov Journal of Genetics and Breeding]. 2015;19(4):460–465. (In Russian). DOI: 10.18699/VJ15.061
3. Carlson B.L., Pokorny J.L., Schroeder M.A., Sarkaria J.N. Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discovery. Curr. Protoc. Pharmacol. 2011;Chapter 14(14):Unit 14.16. DOI: 10.1002/0471141755.ph1416s52
4. Rong L., Li N., Zha Z. Emerging therapies for glioblastoma: Current state and future directions. J. Exp. Clin. Cancer Res. 2022;41(1):142. DOI: 10.1186/s13046-022-02349-7
Review
For citations:
Goryacheva N.A. Orthotopic Model of Human Glioblastoma. Journal Biomed. 2024;20(3E):35-37. (In Russ.) https://doi.org/10.33647/2713-0428-20-3E-35-37
Views:
99
Email this article 
